Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Olaparib/temozolomide

Various toxicities and lack of efficacy: 20 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Schaff LR, et al. Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series. Neurology 99: 750-755, No. 17, 25 Oct 2022. Available from: URL: http://www.neurology.org Schaff LR, et al. Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series. Neurology 99: 750-755, No. 17, 25 Oct 2022. Available from: URL: http://​www.​neurology.​org
Metadaten
Titel
Olaparib/temozolomide
Various toxicities and lack of efficacy: 20 case reports
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-51936-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Lenalidomide

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Catequentinib

Case report

Ketamine